Literature DB >> 10233674

The radiation-attenuated schistosome vaccine induces high levels of protective immunity in the absence of B cells.

S Anderson1, P S Coulson, S Ljubojevic, A P Mountford, R A Wilson.   

Abstract

Radiation-attenuated cercariae of Schistosoma mansoni elicit consistently high levels of protective immunity in mice. The cell-mediated pulmonary effector mechanisms have been well characterized but the role of B cells and antibodies remains ill defined. We have compared the immune responses of B-cell-deficient (muMT) mice and their wild-type (WT) counterparts following exposure to the attenuated vaccine. Both groups mounted a T helper type 1 (Th1)-biased response in the skin-draining lymph nodes after vaccination. Interferon-gamma was the dominant cytokine secreted by airway leucocytes after challenge in both muMT and WT mice, but there was a somewhat greater Th2 component in the former animals. The cellular infiltrates observed in the airways, and the pulmonary effector foci, were of similar composition in the two groups although some large foci were present in the muMT mice. There was a marked dichotomy in the protection induced in muMT animals by a single vaccination, with two-thirds showing levels similar to their WT counterparts, demonstrating that cell-mediated mechanisms alone can provide adequate protection. The remaining muMT mice had a mean worm burden identical to that of their challenge controls. A possible explanation is that a proportion of the muMT animals have a genetic defect closely associated with the mu-heavy-chain locus on chromosome 12, which affects their ability to mount a protective cell-mediated response. Three vaccinations enhanced the immunity of WT animals, most likely by augmenting antibody-mediated mechanisms. In contrast, no enhancement was seen in muMT mice, suggesting that the cell-mediated response is not boosted by multiple exposures to attenuated larvae.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233674      PMCID: PMC2326719          DOI: 10.1046/j.1365-2567.1999.00661.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

Review 1.  Mechanisms of antigen uptake for presentation.

Authors:  A Lanzavecchia
Journal:  Curr Opin Immunol       Date:  1996-06       Impact factor: 7.486

2.  IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite.

Authors:  T A Wynn; A Reynolds; S James; A W Cheever; P Caspar; S Hieny; D Jankovic; M Strand; A Sher
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

3.  Kinetics and mechanism of effector focus formation in the lungs of mice vaccinated with irradiated cercariae of Schistosoma mansoni.

Authors:  L E Smythies; C Betts; P S Coulson; M A Dowling; R A Wilson
Journal:  Parasite Immunol       Date:  1996-07       Impact factor: 2.280

4.  Mouse chromosome 12.

Authors:  P D'Eustachio; R Riblet
Journal:  Mamm Genome       Date:  1997       Impact factor: 2.957

5.  Recruitment of lymphocytes to the lung through vaccination enhances the immunity of mice exposed to irradiated schistosomes.

Authors:  P S Coulson; R A Wilson
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

Review 6.  The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine?

Authors:  P S Coulson
Journal:  Adv Parasitol       Date:  1997       Impact factor: 3.870

7.  A role for B cells in the development of T cell helper function in a malaria infection in mice.

Authors:  J Langhorne; C Cross; E Seixas; C Li; T von der Weid
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

8.  T-helper type-1-dominated lymph node responses induced in C57BL/6 mice by optimally irradiated cercariae of Schistosoma mansoni are down-regulated after challenge infection.

Authors:  R M Pemberton; R A Wilson
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

9.  Antigens derived from lung-stage larvae of Schistosoma mansoni are efficient stimulators of proliferation and gamma interferon secretion by lymphocytes from mice vaccinated with attenuated larvae.

Authors:  A P Mountford; R Harrop; R A Wilson
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling.

Authors:  D Jankovic; A W Cheever; M C Kullberg; T A Wynn; G Yap; P Caspar; F A Lewis; R Clynes; J V Ravetch; A Sher
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

View more
  9 in total

1.  Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models.

Authors:  Workineh Torben; Gul Ahmad; Weidong Zhang; Afzal A Siddiqui
Journal:  Vaccine       Date:  2011-01-28       Impact factor: 3.641

Review 2.  Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century.

Authors:  A G Ross; A C Sleigh; Y Li; G M Davis; G M Williams; Z Jiang; Z Feng; D P McManus
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

3.  Signaling via interleukin-4 receptor alpha chain is required for successful vaccination against schistosomiasis in BALB/c mice.

Authors:  A P Mountford; K G Hogg; P S Coulson; F Brombacher
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 4.  The Road to Elimination: Current State of Schistosomiasis Research and Progress Towards the End Game.

Authors:  Paul Ogongo; Ruth K Nyakundi; Gerald K Chege; Lucy Ochola
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

5.  In the absence of CD154, administration of interleukin-12 restores Th1 responses but not protective immunity to Schistosoma mansoni.

Authors:  James P Hewitson; Paul A Hamblin; Adrian P Mountford
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

6.  Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.

Authors:  Adebayo J Molehin; Souad R Sennoune; Weidong Zhang; Juan U Rojo; Arif J Siddiqui; Karlie A Herrera; Laura Johnson; Justin Sudduth; Jordan May; Afzal A Siddiqui
Journal:  Parasitol Res       Date:  2017-10-12       Impact factor: 2.289

7.  Fasciola hepatica vaccine: we may not be there yet but we're on the right road.

Authors:  Verónica Molina-Hernández; Grace Mulcahy; Jose Pérez; Álvaro Martínez-Moreno; Sheila Donnelly; Sandra M O'Neill; John P Dalton; Krystyna Cwiklinski
Journal:  Vet Parasitol       Date:  2015-01-15       Impact factor: 2.738

8.  Ultraviolet- attenuated cercariae of Schistosoma japonicum fail to effectively induce a Th1 response in spite of up-regulating expression of cytotoxicity-related genes in C57BL/6 mice.

Authors:  Meijuan Zhang; Fang Tian; Yanan Gao; Minjun Ji; Guanling Wu
Journal:  J Biomed Res       Date:  2010-07

Review 9.  Why the radiation-attenuated cercarial immunization studies failed to guide the road for an effective schistosomiasis vaccine: A review.

Authors:  Rashika El Ridi; Hatem Tallima
Journal:  J Adv Res       Date:  2014-10-20       Impact factor: 10.479

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.